Abstract: Phosphate-based glass (P-glass) and poly(⑀-caprolactone) (PCL) composites were fabricated in a sheet form by solvent extraction and thermal pressing methods, and the antibiotic drug Vancomycin was loaded within the composites for use as a hard-tissue regenerative. The degradation and drug-release rate of the composites in vitro were tailored by modifying the glass composition: 0.45P 2 O 5 -xCaO-(0.55-x)Na 2 O, where x ‫؍‬ 0.2, 0.3, 0.4, and 0.5. Compared to pure PCL, all the P-glass/PCL composites degraded to a higher degree, and the composite with lower-CaO glass showed a higher material loss. This was attributed mainly to the dissolution of the glass component. The glass dissolution also increased the degradation of PCL component in the composites. The Vancomycin release from the composites was strongly dependent on the glass composition. Drug release in pure PCL was initially abrupt and flattened out over a prolonged period. However, glass/PCL composites (particularly in the glass containing higher-CaO) exhibited a reduced initial burst and a higher release rate later. Preliminary cell tests on the extracts from the glass/PCL composites showed favorable cell proliferation, but the level was dependent on the ionic concentration of the extracts. The cell proliferation on the diluted extracts from the composite with higher-CaO glass was significantly higher than that on the blank culture dish. These observations confirmed that the P-glass/PCL composites are potentially applicable for use as hard-tissue regeneration and wound-healing materials because of their controlled degradation and drug-release profile as well as enhanced cell viability.
INTRODUCTION
Over the past decade, significant effort has been devoted to the development of applicable biomedical materials due to the lack of autografts and immune and disease problems related to allografts. Moreover, several therapeutic drugs have been administered in the biomaterials in order to improve the efficacy of implants. 1 Many treatments involve the use of therapeutic drugs within the biomaterials themselves, in order to improve implant efficacy. 2 In practice, the drugs retained in implants have been reported to improve the wound-healing and tissue-regeneration rates. 3 Among the biomaterials developed so far, the biodegradable polymers, such as polylactide (PLA), polyglycolide (PGA), polycaprolactone (PCL), and their copolymers, have been studied extensively for use in soft-tissue regeneratives. 4, 5 The PCL, as compared to PGA and PLA, has a much lower degradation rate, and thus has been restricted in its real application. 6 -8 Therefore, in the administration of PCL as a temporary tissue regenerative, attempts have been made to enhance the degradation rate of PCL, for example, by modifying the structure of PCL with hydrophilic polyethylene oxide, and by making copolymers with PLA or PGA. 7, 8 Because PCL is degraded via a hydrolytic process, the introduction of a hydrophilic component was effective in improving the degradation rate. In this manner, the hydrophilic ceramics would be one of the alternatives to improve the hydrophobic property and increase the degradation degree of PCL.
Here we chose phosphate-based glass (P-glass) as a hydrophilic component. P-glass has attracted much attention in hard-tissue engineering, because, like calcium-phosphate (CaP) ceramics, it has an ionic composition similar to that of hard tissue. 9 Moreover, the dissolution of the glass is easily controlled by means of changing the composition. 10 In vitro cellular tests showed that the P-glass with a moderate dissolution rate stimulated osteoblast and fibroblast cell responses. 11 These results on P-glass support the use of its composite with PCL to tailor the degradation rate and improve biocompatibility. Moreover, the glass composite with PCL can enhance flexibility and moldability and extend its application in drug-delivery systems, because, like other CaP ceramics, P-glass alone is highly brittle, lacks flexibility, and is available in limited sizes. In other words, the bioactive-ceramic/ biodegradable-polymer system can be administered for improved biocompatibility.
Recent reports on the ceramic/PCL composites showed that the addition of HA, tricalcium phosphate (TCP), and their biphasics into PCL has increased the degradation rate of the system. [12] [13] [14] [15] [16] [17] A study on the silica-based bioglass-PCL also showed enhanced bioactivity and cell responses. 18, 19 Moreover, the feasibility of the HA/PCL in drug-delivery systems was also addressed.
12,13 P-glasses, compared to other CaP ceramics, have a solubility in a wider range, depending on the composition. 9, 10 This characteristic is potentially useful in tailoring the degradation and drug-release rate of the composites. With regard to P-glass/PCL, Lowry et al. reported its in vivo biological properties, demonstrating the minimal inflammatory reaction in the composite compared to metallic implants. 20 However, there has been no systematic research on the P-glass/PCL composites, particularly on the effect of glass composition on the properties of the composite.
In this study the P-glass/PCL composites were fabricated in a sheet form by novel solvent extraction and thermal pressing methods, and their in vitro degradation and drugrelease rates were examined. Moreover, the osteoblastic cellular responses to the composites were briefly assessed.
MATERIALS AND METHODS

Phosphate Glasses
The preparation method of glass powders was described previously. 21 In brief, four different compositions of P-glasses [0.45P 2 O 5 -xCaO-(0.55-x)Na 2 O, where x ϭ 0.2, 0.3, 0.4, and 0.5] were prepared with the use of P 2 O 5 , NaH 2 PO 4 , and CaCO 3 as starting materials. The precursors were weighed, placed in a Pt crucible, and heat treated between 1100 and 1250°C. The resulting glass melts were quenched on a steel plate and then ground and sieved to obtain fine glass powders.
Glass/PCL Composites
The P-glass/PCL composites were prepared via solvent extraction and thermal pressing techniques. To prepare drugfree samples, PCL (Aldrich) of 10 wt % was dissolved in dimethyl carbonate (DMC, Aldrich) by stirring for 12 h at 70°C. Each glass powder of 10 wt % was dispersed in DMC for 1 h, and then the two solutions were mixed and stirred for 6 h. The mixtures were poured into a vessel containing absolute ethanol, and stirred vigorously to extract the solvent. The coagulated samples were dried under vacuum for 72 h and pressed under a load of 100 kg at 80°C for 5 min.
Vancomycin Drug Loading
Drug-loaded samples were prepared as follows. First, two solutions of Vancomycin in DMC were prepared. The glass powders were dispersed in one of the drug-containing solutions, and the PCL dissolved in DCM was also added to the other drug-containing solution. After both solutions were stirred for 1 h, the glass-drug solution was added to the PCL-drug solution, and the mixture was stirred for 6 h to prepare a drug-containing glass-PCL solution. The amount of glass and PCL was the same as the drug-free samples. The drug amount was fixed at 1% w/w with respect to glass ϩ PCL. The solution was dried and pressed under the same conditions as the drug-free samples. For further tests, the samples were cut to appropriate dimensions and stored under vacuum.
Characterization and Material Degradation
The chemical-bonding structure of the glass-PCL composites was characterized with Fourier-transform infrared (FTIR; System 2000, PerkinElmer) spectroscopy. The morphology of the composites was evaluated by scanning electron microscopy (SEM, JSM-5600, JEOL, Japan).
The samples (10 mm ϫ 10 mm ϫ 0.3 mm) with and without drugs were immersed in a glass vessel containing phosphate-buffered solution (PBS) and incubated at 37°C and pH 7.4 for periods up to 7 days. The medium was refreshed every 1-3 h for the first 24 h, and then every 24 h thereafter. At predetermined periods of time, the samples were taken out, blotted on a filter paper, and weighed with the use of an electronic balance. The water uptake was obtained by the weight difference between wet and initial sample [(W wet / W initial ) Ϫ 1]. The material degradation was obtained from the weight difference between the initial and dried samples [ 
The concentration of the Ca and P released from the composites was measured by means of inductively coupled plasma atomic emission spectroscopy (ICP-AES; Shimadzu, Japan). The degradation of PCL was determined by measuring the weight average (M w ) and number average (M n ) mo-lecular weight by means of gel-permeation chromatography (Waters GPC). Prior to test, 10 mg of each sample was dissolved in 1 mL of tetrahydrofuran (THF, HPLC grade, Aldrich), and filtered through a syringe filter (Millipore). The THF was used as an eluent, and the flow rate and injection volume were 1 mL/min and 100 L, respectively. Instruments were calibrated with the use of low-mass molecular polystyrene standard.
Drug Release
At predetermined periods of time, the samples were taken out and dried, and the drug release was quantified with the use of a UV spectrophotometer (Unicam UV500, ThermoSpectronic, UK) at a wavelength of 280 nm. A calibration curve was obtained with Vancomycin concentrations in the range of 0.2 ϳ 15 (g/mL), in which the curve was linear with a relationship of absorbance ϭ 0.113 ϫ concentration (g/ mL). Special care was taken that the drug amounts lie within the calibrated range by means of diluting the solution with additional PBS. With the use of this relationship, the absorbance measured in the test was directly converted to the drug release.
Three samples in each condition were used for the in vitro degradation and drug-release tests, and data were represented as mean Ϯ 1 standard deviation (1 SD). After in vitro release tests, the surface of the specimens was examined with SEM.
Preliminary Cell Test by Extract
The cell responses to the composites were assessed indirectly on the liquid extracts from the composites. The ionic extracts from the composites were obtained after incubating each sample (0.2CaO and 0.5CaO glass/PCL) in a culture medium (without serum) at 37°C for 3 days, where the ratio of surface area to medium was approximately 0.5 cm 2 /mL, the condition being similar to that of direct cell culturing performed in previous studies. 11 The medium is composed of 10 mL of Dulbecco's modified Eagle medium (DMEM), 2 mM L-glutamine, 50 IU/mL of penicillin, and 50 mg/mL of streptomycin. After dissolution, the Ca and P concentrations were measured by means of ICP-AES.
For cell-proliferation test, the original extracts were diluted in a total culture medium (containing 10% of fetal bovine serum) at different ratios (1:10 and 1:100). The osteoblast-like MG63 cells were seeded at a density of 1 ϫ 10 4 cells/mL on the tissue-culture plastic, which contained the diluted extracts. The cell-proliferation level was assessed in terms of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) method.
11 After 3 and 7 days of culturing, the MTT was added to each well and incubated at 37°C for 4 h. The blue formazan product was dissolved in an acidic solution, and the absorbance was measured at 570 nm with the use of a spectrophotometer.
The tests were performed on six replicate samples for each condition, and data were represented as mean Ϯ 1 SD for n ϭ 6. Statistical analysis was carried out by means of one-way analysis of variance (ANOVA). Statistical significance was considered at p Ͻ 0.05 and p Ͻ 0.01. Figure 1 shows the typical SEM morphology of the glass/ PCL composite (A) before and (B) after degradation. Morphology of the 0.4 CaO-glass/PCL composite is shown as a representative example. In the as-fabricated composite, the glass particles were dispersed uniformly through the PCL sheet in several micrometers [ Figure 1(A) ]. After degradation test for 7 days, some pits were formed on the surface, due to the material loss [ Figure 1(B) ]. The morphology of other composites was similar to that of 0.4CaO glass/PCL, with a difference only in the degree of pits on the surface (data not shown).
RESULTS
Material Degradation
The weight changes of the dried and wet samples with incubation for up to 7 days are shown in Figure 2(A,B) , respectively. Data on the dried sample means the total mate- rial loss with incubation [ Figure 2(A) ]. In pure PCL, the weight loss was minimal, but the glass/PCL composites showed weight losses clearly. Among the composites, the glass containing lower CaO concentration had higher weight loss. The composite with 0.5CaO glass exhibited almost linear weight loss with time, while the other composites showed a fast initial loss and further decreased rate. Figure 2 (B) shows the weight change measured on the wet samples, explaining the degree of both material loss and water absorption. The weight of the pure PCL increased slightly. The glass/PCL composites showed quite a different weight change depending on the glass composition: In the composites with high-CaO glasses (0.4 and 0.5 CaO), a weight gain was observed; however, in the other cases, a weight loss was observed. When the CaO concentration was high (0.4 and 0.5CaO), the water absorption prevailed on the
The Ca and P concentrations released from the samples with incubation are shown in Figure 3 . The composite with higher-CaO glass released lower concentrations of both Ca and P. The ionic release from the 0.2CaO glass/PCL was about 2-4 times higher than that from the 0.5CaO glass/PCL, after 7 days. Figure 4 shows the FTIR spectroscopy of the PCL and glass-PCL composites with different glass compositions (A) before and (B) after degradation test for 7 days. In the glass-PCL composites, additional phosphate bands (indicated as arrows) were observed in a similar manner, without regard to the glass composition [ Figure 4(A) ]. When the samples were incubated for 7 days [ Figure 4 (B)], the bands related with glass were attenuated notably in the composites with low-CaO glasses (0.2 and 0.3CaO), whereas those with high- CaO glasses (0.4 and 0.5CaO) retained their initial intensities for the most part. Table I shows the change in number and weight average molecular weight of PCL in the samples with incubation for 7 and 14 days. Compared to pure PCL, the PCL from the glass/PCL composites showed a more significant reduction in the molecular weights, and more so in the composite containing lower CaO concentration. Figure 5(A,B) show the amount of drugs released from the pure PCL and glass/PCL composites. Vancomycin was loaded initially at 1% in all samples. In pure PCL, the drug was released abruptly during the initial period, but the rate was slowed down thereafter [ Figure 5 (A)]. Compared to PCL, the composites showed higher drug release, particularly at prolonged periods. On closer examination of data (insets), the initial burst effect within several hours was reduced in the composites, and more so with higher CaO concentration. The data on Figure 5 (A) were normalized to the total drug amount loaded initially [ Figure 5(B) ]. The release data on PCL were positioned in the middle of the composites. In all composites, the initial burst was lower than that in pure PCL. The drug-release amount was approximately 60 -80% of the total loading amount. Figure 6 shows the weight change of the drug-loaded samples in (A) dry and (B) wet states. For all cases, the trends were similar to the drug-free samples (compare with Figure  2 ). On closer examination, the weight change in the drugloaded samples was slightly higher than that in the drug-free samples.
Cell Viability
The cellular responses to the glass/PCL composites were assessed by an indirect extraction method. The ions from the samples were extracted and diluted at different concentrations, and the osteoblast-like MG63 cells were cultured on the plastic culture dish containing the diluted extracts. The blank culture dish without extract was used as a control. The concentrations of Ca and P of the diluted extracts are summarized in Table II . MG63 cell proliferation levels on the plastic culture dish containing various concentrations of extracts from the samples after 3 and 7 days of culturing, as assessed by an MTT method. The extracts were prepared by incubating the samples in a culture medium (serum free) for 3 days, and were diluted to various concentrations with a total culture medium (with 10% FBS). Blank culture medium without the extracts was used as a control. Statistical significance was considered at *p Ͻ 0.05 and **p Ͻ 0.01 with respect to the blank medium. The cell-proliferation level was assessed by an MTT method after 3 and 7 days of culturing, as represented in Figure 7 . The cell proliferation on the original extract from the 0.2CaO glass/PCL was significantly lower than that on the control (p Ͻ 0.05 at Day 3 and p Ͻ 0.01 at Day 7). On the extracts diluted to 1/10 and 1/100, the cell proliferation increased greatly, and the value was significantly higher (p Ͻ 0.05) at Day 3 for 1/100 dilution, but lower (p Ͻ 0.05) at Day 7 for 1/10 dilution, with respect to control. In particular, on the original extract from the 0.5CaO glass/PCL, the cell proliferation was comparable to that on the control. On the extract diluted to 1/10, the cell proliferation was significantly higher (p Ͻ 0.01 at Day 3 and p Ͻ 0.05 at Day 7) with respect to control.
DISCUSSION
Ceramic-polymer biological composites have gained significant attention in the field of biomaterials, with researchers focused on the improvement of the biocompatibility by optimizing the biological and mechanical properties of each component. The P-glass/polycaprolactone composites exploited in this study are also expected to provide these beneficial aspects. Although the PCL is nontoxic and useful for delivering drugs, it has a high hydrophobicity and low degradation rate, thus limiting its wide application. 7, 8 The Pglass, possessing bioactivity and compositional similarity to bones and teeth, has high potential as a hard-tissue replacement. 9, 10 However, the glass is brittle and difficult to handle, so its use was limited to only small and non-load-bearing parts.
Previously, the authors had observed that the mechanical properties of the CaP/PCL composites were improved as compared to the CaP or PCL single-component materials. 13 In the HA/PCL coatings, the ceramic powder enhanced water-uptake capacity and the degradation rate of PCL. 12 Recently, the addition of tricalcium phosphate (TCP) was also reported to increase the degradation of polyester copolymers.
14 The P-glass, as compared to the CaP ceramics (HA and TCP) or silica glass, is much more soluble. Of particular note, the solubility of the P-glass can be easily controlled by the compositional change, 10 and this is beneficial for controlling the degradation and drug-release rate of the composites.
The solubility of the P-glass was varied by changing the CaO/Na 2 O ratio at a fixed P 2 O 5 , with the composition of 0.45P 2 O 5 -xCaO-(0.55-x)Na 2 O. In pure glasses of these compositions, higher CaO concentration was observed to lower the solubility of the glass. 9, 10 Likewise, in the glass-PCL composites, the trend in pure glass was similarly observed; that is, the ionic release of glass was lower in composites with higher-CaO glass.
This dissolution of the glass component directly influenced the degradation of the composites; that is, the weight loss of the composites increased with decreasing CaO concentration in glass. The weight loss of the composites was also attributed partially to the degradation of PCL, because the molecular weight of PCL was decreased with the addition of glass. Because the PCL degrades through a hydrolytic process, the existence of a glass phase in the PCL should enhance the water absorption and further hydrolytic degradation of PCL. In practice, in the TCP-containing PLGC copolymer, the degradation of PLGC was reported to increase. 14 As a drug carrier, the efficacy of the glass/PCL composites was addressed by encapsulating and releasing an antibiotic drug Vancomycin. The drug-release profile was highly dependent on the degradation of the composites. The higher the CaO concentration in glass, the lower the drug release of the composite, and this was more obvious at an initial period. When compared to the pure PCL, the glass/PCL composites had lower initial burst, and more so in the composite with higher-CaO glass. The high initial burst in PCL was due to the free drug on the surface, where it was not encapsulated efficiently. The abrupt decrease in release rate after the initial burst was also due to the hydrophobicity of PCL, because the inside drug would diffuse out very slowly. However, when the glass was added to PCL, the initial burst effect decreased significantly, and the release rate was further enhanced, and these were highly dependent on the glass composition. Because of its high hydrophilicity, the drugs would adhere to the glass to a significant level. Practically, the hydrophilic drugs have high affinity to the calcium-phosphate materials. 22 The drugs on the glass should be released by both the direct dissolution of glass and the diffusion through water channel. 13 Based on the weight-change data (Figure 6 ), the dissolution phenomenon is considered to prevail on the water absorption in the composites with low-CaO glasses (0.2 and 0.3 CaO). Thus, the drugs on the low-CaO glasses were released more at an initial stage by the dissolution of glasses on the surface. However, the initial burst in the composites with high-CaO glasses could be suppressed. In this manner, the 0.5CaO glass is considered to be more favorable in the drug-delivering system, because of its reduced initial burst and continuous and prolonged release.
Cell compatibility of the glass/PCL composites was assessed preliminarily by using their extracts. Because the composites release considerable amounts of ions, the ionic effects on the cell behavior need to be surveyed. The MG63 cells proliferated well on the extracts (both original and dilutions). In particular, the cell proliferation was significantly up-regulated on the extracts at certain ionic concentrations. When compared to the composite containing highly dissolvable glass (0.2CaO), the one with less-soluble glass (0.5CaO) showed a higher proliferation level. In pure P-glass, the enhanced cell responses were also observed on the lesssoluble glass, suggesting there should be some ionic range appropriate for the cellular activity. 11 However, this differing cellular response depending on the ionic concentration is not considered to be from the pH effect of the extracts, because the pHs of the original and diluted samples were not much different (well above 7.0). Although the substrate effect was not considered in the extract test, at least by this test the concentration range of the dissolved ions, which is appropriate for cellular responses, can be surmised. Furthermore, the osteoblastic stimulation was confirmed at the proliferation level within appropriate ionic concentrations. However, in an in vivo situation, the biological fluid circulates and the ions concentrated locally neutralize continuously. As such, this ionic concentration index for the favorable osteoblastic proliferation still cannot tell the whole story occurring in vivo. Therefore, in vivo animal tests on the glass/PCL composites with varying glass composition are required as further study.
Based on these observations, the introduction of P-glass into PCL is considered to have some potential for hard-tissue regeneration, because of its improving hydrophilicity and degradation rate, efficient hydrophilic drug delivery, and favorable affect on cellular responses by the ionic dissolution.
CONCLUSIONS
Phosphate glass (P-glass)/polycaprolactone (PCL) composites were fabricated and loaded with Vancomycin for tissueregeneration and wound-healing applications. The composition of glass was varied [0.45P 2 O 5 -xCaO-(0.55-x)Na 2 O, where x ϭ 0.2, 0.3, 0.4, and 0.5] in order to control the degradation and drug release. Compared to pure PCL, the composites showed higher weight losses, and more so with increasing CaO concentration in glass. The PCL also degraded more significantly by the addition of glass. Compared to pure PCL, the composites released drug at lower amount initially but at higher rate over a prolonged period. The enhanced degradation and controlled drug release of the P-glass/PCL composites were attributed to the high capacity of water uptake and the different dissolution rates of the glasses depending on the composition. The osteoblastic cells proliferated favorably on the extracts from the composites, and the level was significantly improved at certain ionic concentrations. These results suggested the composites are potentially useful as a hard-tissue regenerative.
